Compare A & TECK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | A | TECK |
|---|---|---|
| Founded | 1999 | 1913 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.0B | 32.4B |
| IPO Year | 1999 | 1997 |
| Metric | A | TECK |
|---|---|---|
| Price | $173.82 | $59.16 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 22 | 17 |
| Target Price | ★ $181.05 | $56.86 |
| AVG Volume (30 Days) | 1.6M | ★ 2.2M |
| Earning Date | 11-23-2026 | 10-29-2026 |
| Dividend Yield | 0.57% | ★ 0.58% |
| EPS Growth | ★ 3.16 | N/A |
| EPS | ★ 3.55 | N/A |
| Revenue | ★ $4,472,000,000.00 | N/A |
| Revenue This Year | $7.95 | $41.13 |
| Revenue Next Year | $6.41 | $1.88 |
| P/E Ratio | $50.12 | ★ $32.94 |
| Revenue Growth | ★ 6.43 | N/A |
| 52 Week Low | $108.35 | $38.00 |
| 52 Week High | $178.21 | $72.56 |
| Indicator | A | TECK |
|---|---|---|
| Relative Strength Index (RSI) | 58.50 | 33.02 |
| Support Level | $163.32 | $58.91 |
| Resistance Level | $177.05 | $61.52 |
| Average True Range (ATR) | 4.97 | 1.73 |
| MACD | -0.38 | -0.64 |
| Stochastic Oscillator | 66.51 | 4.15 |
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Teck is a base metals miner with copper and zinc operations in Canada, the United States, Chile, and Peru. After selling its metallurgical coal business, copper is now its major commodity by EBITDA contribution, followed by zinc. Teck is a top-three zinc miner. Its major new copper mine in Chile at the majority-owned Quebrada Blanca 2, in partnership with Sumitomo, will drive an increase in Teck's attributable copper production by roughly 80%. Along with a number of additional copper growth options, Teck's strategy is to rebalance its portfolio to low-carbon metals such as copper. It sold its oil sands business in early 2023 and its coal business in mid-2024. In September 2025, it agreed to merge with Anglo American in an all-equity deal.